Veradigm delays Q1 2026 10-Q filing, cites unreasonable effort and expense

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc.

MDRX

0.00

  • Veradigm filed a late notice for its quarterly report for period ended March 31, 2026, citing inability to file on time without unreasonable effort or expense.
  • Delay ties to earlier internal control failures that led board to conclude prior financial statements should not be relied upon due to revenue misstatements, followed by additional misstatements affecting 2020 financial statements.
  • Company remains behind on multiple periodic reports from 2023 through 2025, with no definitive timeline provided for filing delinquent reports.
  • Nasdaq delisted company stock in April 2024 due to ongoing noncompliance with timely SEC filing and annual meeting requirements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradigm Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-219423), on May 12, 2026, and is solely responsible for the information contained therein.